Pfizer, Inc. Sees FDA Withdrawal of Approval for Four Animal Drug Applications

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of four new animal drug applications (NADA's) submitted by Pfizer, Inc. for the use of oxytetracycline hydrochloride, following a request from the sponsor due to the discontinuation of animal drug product manufacturing and marketing.